UK markets closed

Eledon Pharmaceuticals, Inc. (ELDN)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.5900-0.0500 (-3.05%)
As of 11:37AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
30,312
30,312
27,080
23,735
6,131
Selling general and administrative
12,688
12,688
12,700
13,132
10,052
Total operating expenses
43,000
43,000
39,780
36,867
16,183
Operating income or loss
-43,000
-43,000
-39,780
-36,867
-16,183
Total other income/expenses net
2,674
2,674
-48,186
7
-2,203
Income before tax
-40,326
-40,326
-87,966
-36,860
-23,215
Income tax expense
0
0
0
-2,354
-404
Income from continuing operations
-40,326
-40,326
-87,966
-34,506
-22,811
Net income
-40,326
-40,326
-87,966
-34,506
-22,811
Net income available to common shareholders
-40,326
-40,326
-87,966
-34,506
-22,811
Basic EPS
-2.33
-1.64
-6.16
-2.33
-15.72
Diluted EPS
-2.33
-1.64
-6.16
-2.33
-15.72
Basic average shares
14,820
24,619
14,285
14,820
1,451
Diluted average shares
14,820
24,619
14,285
14,820
1,451